A Randomized, Double-Blind, Placebo Controlled Study Of Quetiapine SR (QTP) As Adjunctive Treatment In Mixed States (MS) Of Bipolar Disorder

Trial Profile

A Randomized, Double-Blind, Placebo Controlled Study Of Quetiapine SR (QTP) As Adjunctive Treatment In Mixed States (MS) Of Bipolar Disorder

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Mar 2017

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Bipolar disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Feb 2013 AstraZeneca added as trial company and lead trial centre as reported by ClinicalTrials.gov.
    • 01 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top